Cardiovascular Systems Inc. (CSII)

22.45
0.07 0.31
NASDAQ : Health Technology
Prev Close 22.52
Open 22.58
Day Low/High 22.21 / 22.74
52 Wk Low/High 20.58 / 33.11
Volume 66.36K
Avg Volume 297.60K
Exchange NASDAQ
Shares Outstanding 33.22M
Market Cap 753.72M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems, Inc. Announces First Patients Treated From Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device

Cardiovascular Systems, Inc. Announces First Patients Treated From Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today...

Cardiovascular Systems, Inc. Appoints Jeff Points As Chief Financial Officer

Cardiovascular Systems, Inc. Appoints Jeff Points As Chief Financial Officer

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately.

Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems, Inc. To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

Cardiovascular Systems, Inc. To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

On Wednesday, February 14, 2018, Cardiovascular Systems' (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the LEERINK Partners 7 th Annual Global Healthcare Conference at 10:30 a.

Cardiovascular Systems, Inc. Announces Commercial Launch In Japan

Cardiovascular Systems, Inc. Announces Commercial Launch In Japan

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced...

Noteworthy Wednesday Option Activity: CSII, GME, ACAD

Noteworthy Wednesday Option Activity: CSII, GME, ACAD

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cardiovascular Systems, Inc , where a total volume of 1,104 contracts has been traded thus far today, a contract volume which is representative of approximately 110,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50.9% of CSII's average daily trading volume over the past month, of 217,075 shares.

Cardiovascular Systems, Inc. Appoints Rhonda Robb As New Chief Operating Officer

Cardiovascular Systems, Inc. Appoints Rhonda Robb As New Chief Operating Officer

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today announced that it has...

First Week of CSII February 16th Options Trading

First Week of CSII February 16th Options Trading

Investors in Cardiovascular Systems, Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CSII options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

Cardiovascular Systems Expands Product Portfolio To Further Support Peripheral And Coronary Interventions

Cardiovascular Systems Expands Product Portfolio To Further Support Peripheral And Coronary Interventions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today...

Cardiovascular Systems To Webcast Fiscal 2018 Second-Quarter Earnings Conference Call Wednesday, February 7

Cardiovascular Systems To Webcast Fiscal 2018 Second-Quarter Earnings Conference Call Wednesday, February 7

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 second-quarter conference call on Wednesday, February 7, 2018, at 3:45 p.

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Cardiovascular Systems, Inc. (CSII)

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Cardiovascular Systems, Inc. (CSII)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that it is investigating whether certain officers and directors of Cardiovascular...

Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Cardiovascular Systems, Inc. (CSII)

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Cardiovascular Systems, Inc. (CSII)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain officers and directors of Cardiovascular Systems, Inc.

Cardiovascular Systems To Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25

Cardiovascular Systems To Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.

CSII Crosses Below Key Moving Average Level

CSII Crosses Below Key Moving Average Level

In trading on Monday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $28.76, changing hands as low as $28.15 per share. Cardiovascular Systems, Inc shares are currently trading down about 7.2% on the day.

Cardiovascular Systems Announces Anticipated Revenue Impact From Hurricanes Harvey And Irma

Cardiovascular Systems Announces Anticipated Revenue Impact From Hurricanes Harvey And Irma

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter...

LIBERTY 360° Study 12-Month Data Demonstrate Lasting Benefits Following Endovascular Intervention In Patients With Critical Limb Ischemia (CLI)

LIBERTY 360° Study 12-Month Data Demonstrate Lasting Benefits Following Endovascular Intervention In Patients With Critical Limb Ischemia (CLI)

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today released one-year data from its LIBERTY 360° clinical study in a late-breaking presentation at the 2017 Amputation Prevention Symposium (AMP) in Chicago.

Cardiovascular Systems, Inc. Reports Fiscal 2017 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2017 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, August 2, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $52.

Cardiovascular Systems To Webcast Fiscal 2017 Fourth-Quarter Earnings Conference Call Wednesday, August 2

Cardiovascular Systems To Webcast Fiscal 2017 Fourth-Quarter Earnings Conference Call Wednesday, August 2

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2017 fourth-quarter conference call on Wednesday, August 2, 2017, at 3:45 p.

Cardiovascular Systems To Present At The JMP Securities Life Sciences Conference

On Wednesday, June 21, 2017, Cardiovascular Systems' (NASDAQ: CSII) Chief Financial Officer, Larry Betterley, will present at the JMP Securities Life Sciences Conference at 11:30 a.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATRO, BLL, CCE, CSII, EGN, EMR, HCI, IMPV, K, MANT, MLCO, MX, OI, RDS.A, RDS.B, TPRE, USCR, WMC Downgrades: CCO, CLF, GCAP, INCY, KMPR, OMCL, OMI, SHEN, SWIR, UEPS Initiations: ORMP Read on to get TheStreet Quant Ratings' detailed report:

FDA Approves Cardiovascular Systems' Replacement Saline Infusion Pump

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced that the U.

Cardiovascular Systems, Inc. Reports Fiscal 2017 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, May 3, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $52.

Cardiovascular Systems Reaches Analyst Target Price

In recent trading, shares of Cardiovascular Systems, Inc have crossed above the average analyst 12-month target price of $30.50, changing hands for $30.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Thousands In Phoenix May Be Affected By Peripheral Artery Disease (PAD)

PAD is the biggest disease that most people have never heard about.

Thousands In Philadelphia May Be Affected By Peripheral Artery Disease (PAD)

PAD is the biggest disease that most people have never heard about.

TheStreet Quant Rating: C- (Hold)